Golden State Medical Supply Inc. recalls Carbamazepine Tablets
- Published
- 26 Aug 2026
- Units affected
- 1200 bottles
- Agency
- FDA
- Country
- United States
The hazard
CGMP deviations: tablets with black specks.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
- Brand / company
- Golden State Medical Supply Inc.
- Codes / lots
- Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
- Distribution
- USA Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 26 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.